Drug Profile
Gamma-tocotrienol - Davos
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Davos Life Science
- Class Antihypertensives; Chromans
- Mechanism of Action Apoptosis stimulants; Gene expression inhibitors; Growth inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hypercholesterolaemia; Solid tumours
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Hypercholesterolaemia in Japan
- 16 Jul 2016 No recent reports of development identified for preclinical development in Solid-tumours in Australia
- 16 Jul 2016 No recent reports of development identified for preclinical development in Solid-tumours in Hong Kong